{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:51:48Z","timestamp":1791550308037,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.hbpd.2026.07.004","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:19:51Z","timestamp":1783700391000},"page":"570-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progression of sarcopenia among patients with pancreatic ductal adenocarcinoma receiving neoadjuvant therapy and the impact of pancreatic enzyme replacement therapy"],"prefix":"10.1016","volume":"25","author":[{"given":"Jyotsna","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupaly","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith J","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2026.07.004_bib0001","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1200\/JCO.19.02274","article-title":"Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the Dutch randomized phase III PREOPANC trial","volume":"38","author":"Versteijne","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0002","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12893-017-0291-1","article-title":"Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1))-study protocol for a national multicentre randomized controlled trial","volume":"17","author":"Labori","year":"2017","journal-title":"BMC Surg"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0003","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jso.27251","article-title":"Can sarcopenia predict complete response after total neoadjuvant therapy in advanced rectal cancer? A multicentre observational cohort study","volume":"128","author":"Bedrikovetski","year":"2023","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0004","first-page":"80","article-title":"Neoadjuvant therapy (NAT) in localized pancreatic cancer: should we do it and what should we do?","volume":"2","author":"Goyal","year":"2021","journal-title":"J Cell Signal"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0006","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijsu.2018.09.014","article-title":"Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: systematic review and meta-analysis","volume":"59","author":"Mintziras","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0007","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.clnu.2017.07.010","article-title":"Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: a systematic review","volume":"37","author":"Pamoukdjian","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0008","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pan.2018.10.010","article-title":"Enzyme replacement improves survival among patients with pancreatic cancer: results of a population based study","volume":"19","author":"Roberts","year":"2019","journal-title":"Pancreatology"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0009","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pan.2025.02.015","article-title":"Recommendations from the European guidelines for the diagnosis and therapy of pancreatic exocrine insufficiency","volume":"25","author":"Vujasinovic","year":"2025","journal-title":"Pancreatology"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0010","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.hpb.2019.05.018","article-title":"Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis","volume":"21","author":"Bundred","year":"2019","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0011","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.3390\/jcm10143033","article-title":"The prognostic value of low muscle mass in pancreatic cancer patients: a systematic review and meta-analysis","volume":"10","author":"Pierobon","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0012","article-title":"Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: a systematic review","volume":"12","author":"Rizzo","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0013","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jgo.2018.03.002","article-title":"The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancer","volume":"9","author":"Benjamin","year":"2018","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0014","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3390\/cancers11050709","article-title":"Continued weight loss and sarcopenia predict poor outcomes in locally advanced pancreatic cancer treated with chemoradiation","volume":"11","author":"Naumann","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/jamasurg.2018.0979","article-title":"Association between changes in body composition and neoadjuvant treatment for pancreatic cancer","volume":"153","author":"Sandini","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0016","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1245\/s10434-014-4285-2","article-title":"Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer","volume":"22","author":"Cooper","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0017","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6004\/jnccn.2021.0017","article-title":"Pancreatic adenocarcinoma, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Tempero","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0018","unstructured":"Campbell F, Cairns A, Duthie F, Feakins R. Dataset for histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct. [cited 26 Aug 2025]. Available from: https:\/\/www.rcpath.org\/static\/34910231-c106-4629-a2de9e9ae6f87ac1\/G091-Dataset-for-histopathological-reporting-of-carcinomas-of-the-pancreas-ampulla-of-Vater-and-common-bile-duct.pdf."},{"key":"10.1016\/j.hbpd.2026.07.004_bib0019","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3945\/ajcn.115.111203","article-title":"What is the best reference site for a single MRI slice to assess whole-body skeletal muscle and adipose tissue volumes in healthy adults?","volume":"102","author":"Schweitzer","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0021","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12957-020-01836-5","article-title":"Impact of intramuscular adipose tissue content on short- and long-term outcomes of hepatectomy for colorectal liver metastasis: a retrospective analysis","volume":"18","author":"Horii","year":"2020","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0022","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","article-title":"Strengthening the reporting of observational studies in Epidemiology (STROBE): explanation and elaboration","volume":"12","author":"Vandenbroucke","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0023","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijsu.2018.09.014","article-title":"Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: systematic review and meta-analysis","volume":"59","author":"Mintziras","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0024","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11864-019-0691-9","article-title":"Chemotherapy-induced sarcopenia","volume":"21","author":"Bozzetti","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4251\/wjgo.v11.i7.527","article-title":"Sarcopenia in pancreatic cancer-effects on surgical outcomes and chemotherapy","volume":"11","author":"Chan","year":"2019","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0026","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3390\/cancers12020275","article-title":"Pancreatic enzyme replacement therapy in pancreatic cancer","volume":"12","author":"Pezzilli","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0027","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/bjs.9342","article-title":"Prospective assessment of the influence of pancreatic cancer resection on exocrine pancreatic function","volume":"101","author":"Sikkens","year":"2014","journal-title":"J Br Surg"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0028","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/nu9030183","article-title":"Pancreatic exocrine insufficiency in pancreatic cancer","volume":"9","author":"Vujasinovic","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0029","article-title":"Body composition as a predictor of chemotherapy-related toxicity in pancreatic cancer patients: a systematic review","volume":"12","author":"Rizzo","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0030","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s12603-018-1139-9","article-title":"International clinical practice guidelines for sarcopenia (ICFSR): screening, diagnosis and management","volume":"22","author":"Dent","year":"2018","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0031","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.pan.2022.08.009","article-title":"Systemic inflammation response index correlates with survival and predicts oncological outcome of resected pancreatic cancer following neoadjuvant chemotherapy","volume":"22","author":"Kim","year":"2022","journal-title":"Pancreatology"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0032","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1245\/s10434-019-08094-0","article-title":"Prognostic value of the systemic immune-inflammation index (SII) after neoadjuvant therapy for patients with resected pancreatic cancer","volume":"27","author":"Murthy","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0033","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.biocel.2013.05.032","article-title":"Muscle wasting in cancer","volume":"45","author":"Johns","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0034","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/CE.S26705","article-title":"Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency","volume":"7","author":"Nakajima","year":"2012","journal-title":"Core Evid"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/geriatrics2010011","article-title":"Intramuscular adipose tissue and the functional components of sarcopenia in hospitalized geriatric patients","volume":"2","author":"Perkisas","year":"2017","journal-title":"Geriatrics"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0036","doi-asserted-by":"crossref","first-page":"147","DOI":"10.21873\/cdp.10301","article-title":"Preoperative myosteatosis and prognostic nutritional index predict survival in older patients with resected biliary tract cancer","volume":"4","author":"Utsumi","year":"2024","journal-title":"Cancer Diagn Progn"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0037","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.clnu.2021.03.036","article-title":"Modified intramuscular adipose tissue content as a feasible surrogate marker for malnutrition in gastrointestinal cancer","volume":"40","author":"Kusunoki","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0038","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12957-020-01836-5","article-title":"Impact of intramuscular adipose tissue content on short- and long-term outcomes of hepatectomy for colorectal liver metastasis: a retrospective analysis","volume":"18","author":"Horii","year":"2020","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0039","unstructured":"National Institute for Health and Care Excellence (NICE). Pancreatic cancer in adults: diagnosis and management. [cited 26 Aug 2025]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng85."},{"key":"10.1016\/j.hbpd.2026.07.004_bib0040","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/2050640620938987","article-title":"Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: a systematic review and meta-analysis","volume":"8","author":"de la Iglesia","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0041","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.pan.2019.07.039","article-title":"Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer","volume":"19","author":"Griffin","year":"2019","journal-title":"Pancreatology"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0042","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/01635581.2020.1870704","article-title":"Body composition and response and outcome of neoadjuvant treatment for pancreatic cancer","volume":"74","author":"Jin","year":"2022","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0043","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s11605-017-3618-4","article-title":"Anthropometric changes in patients with pancreatic cancer undergoing preoperative therapy and pancreatoduodenectomy","volume":"22","author":"Cloyd","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0044","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s10147-023-02321-1","article-title":"Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer","volume":"28","author":"Nakajima","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0045","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.21873\/anticanres.13711","article-title":"Change in PMI during neoadjuvant therapy is a predictive prognostic marker in rectal cancer","volume":"39","author":"Fukuoka","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0046","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1080\/07853890.2022.2081872","article-title":"Low Psoas-Muscle index is associated with decreased survival in hepatocellular carcinoma treated with transarterial chemoembolization","volume":"54","author":"Zhang","year":"2022","journal-title":"Ann Med"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0047","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.surg.2015.08.047","article-title":"Impact of the preoperative quantity and quality of skeletal muscle on outcomes after resection of extrahepatic biliary malignancies","volume":"159","author":"Okumura","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0048","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s12603-010-0081-2","article-title":"Skeletal muscle fat infiltration: impact of age, inactivity, and exercise","volume":"14","author":"Marcus","year":"2010","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2019.102839","article-title":"Myosteatosis and prognosis in cancer: systematic review and meta-analysis","volume":"145","author":"Aleixo","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0050","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.3390\/jcm11237129","article-title":"Impact of preoperative handgrip strength on postoperative outcome after radical gastrectomy for gastric cancer patients","volume":"11","author":"Matsui","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.hbpd.2026.07.004_bib0051","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12916-017-0783-y","article-title":"Practical guide to exocrine pancreatic insufficiency-Breaking the myths","volume":"15","author":"Struyvenberg","year":"2017","journal-title":"BMC Med"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387226001141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387226001141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:56:47Z","timestamp":1791547007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387226001141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1499387226001141"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2026.07.004","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression of sarcopenia among patients with pancreatic ductal adenocarcinoma receiving neoadjuvant therapy and the impact of pancreatic enzyme replacement therapy","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2026.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}